David J Byrne

10PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 05, 2024
Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies.

Jin Ng, Ling Cai, Luc Girard

|Nov 22, 2023
Spatial transcriptomics and the anatomical pathologist: Molecular meets morphology.

Jia-Min B Pang, David J Byrne, Alice R T Bergin

|Aug 26, 2022
Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status.

Javier Octavio Mejía-Hernández, Dinesh Raghu, Franco Caramia

|Jan 20, 2022
Using Genomic Sequencing to Explain an Exceptional Response to Therapy in a Malignant Phyllodes Tumor.

Ciara Conduit, Stephen Luen, Huiling Xu

|Sep 03, 2020
A MXI1-NUTM1 fusion protein with MYC-like activity suggests a novel oncogenic mechanism in a subset of NUTM1-rearranged tumors.

Christopher R McEvoy, Holly Holliday, Niko Thio

|Aug 18, 2020
The TP53 mutation rate differs in breast cancers that arise in women with high or low mammographic density.

Dane Cheasley, Lisa Devereux, Siobhan Hughes

Pageof 2